Association of Variants Near the Bradykinin Receptor B2 Gene With Angioedema in Patients Taking ACE Inhibitors-Reference-Cited by-同舟云学术

Association of Variants Near the Bradykinin Receptor B2 Gene With Angioedema in Patients Taking ACE Inhibitors

Published:2021-08 Issue:7 Volume:78 Page:696-709
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Ghouse Jonas,Ahlberg Gustav,Andreasen Laura,Banasik Karina,Brunak Søren,Schwinn Michael,Larsen Ina Holst,Petersen Oscar,Sørensen Erik,Ullum Henrik,Rasmussen Eva Rye,Eriksson Niclas,Hallberg Pär,Wadelius Mia,Bundgaard Henning,Olesen Morten S.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference37 articles.

1. Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial;Kostis;Am J Hypertens,2004

2. Angiotensin-converting enzyme inhibitor–induced angioedema: a review of the literature;Brown;J Clin Hypertens,2017

3. Increasing rate of angiotensin-converting enzyme inhibitor-related upper airway angio-oedema;Holm;Dan Med J,2012

4. Multicenter study of patients with angiotensin-converting enzyme inhibitor-induced angioedema who present to the emergency department;Banerji;Ann Allergy Asthma Immunol,2008

5. Bradykinin-mediated angioedema;Nussberger;N Engl J Med,2002

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A pharmacovigilance study assessing risk of angioedema with angiotensin receptor blockers using the US FDA Adverse Event Reporting System;Expert Opinion on Drug Safety;2024-08-19

2. Cardiovascular Pharmacogenetics: From Discovery of Genetic Association to Clinical Adoption of Derived Test;Pharmacological Reviews;2024-08-09

3. Bradykinin attenuates endothelial-mesenchymal transition following cardiac ischemia-reperfusion injury;European Journal of Pharmacology;2024-05

4. Meta-analysis of ACE inhibitor–induced angioedema identifies novel risk locus;Journal of Allergy and Clinical Immunology;2024-04

5. Pharmacogenomic knowledge and awareness among diverse patients treated with angiotensin converting enzyme inhibitors;Pharmacogenomics;2023-12